Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0000950170-25-013697

Chief Executive Officer acquired 68,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-31 Grant or award : show line 1 in the form +68,100 145,321 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-31 Grant or award : show line 2 in the form Stock options (right to buy) +228,800 228,800 D
Loading xslF345X05/ownership.xml…